PCSK9 inhibition: Not just LDL-Cholesterol knock down: A glimmer for cancer

被引：4
|
作者：
Patrono, Carlo [1 ,2 ]
Volpe, Massimo [3 ]
机构：
[1] Catholic Univ, Sch Med, Pharmacol, Rome, Italy
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Sapienza Univ Rome, St Andrea Hosp, Cardiol, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷 / 12期
关键词：
D O I：
10.1093/eurheartj/ehab047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1130 / 1131
页数：2
相关论文
共 50 条
  • [1] PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering
    Cariou, Bertrand
    Ding, Zufeng
    Mehta, Jawahar L.
    [J]. ATHEROSCLEROSIS, 2016, 253 : 275 - 277
  • [2] PCSK9 MUTATIONS AND LDL-CHOLESTEROL IN THE BOGALUSA HEART STUDY
    Hallman, D. M.
    Srinivasan, S.
    Chen, W.
    Boerwinkle, E.
    Berenson, G.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [3] PCSK9—an exciting target for reducing LDL-cholesterol levels
    D. John Betteridge
    [J]. Nature Reviews Endocrinology, 2013, 9 : 76 - 78
  • [4] LDL-cholesterol targets: perspectives for the use of PCSK9 inhibitors
    Luscher, Thomas F.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (17) : 1337 - 1340
  • [5] The crystal structure of PCSK9: A regulator of plasma LDL-cholesterol
    Piper, Derek E.
    Jackson, Simon
    Liu, Qiang
    Romanow, William G.
    Shetterly, Susan
    Thibault, Stephen T.
    Shan, Bei
    Walker, Nigel P. C.
    [J]. STRUCTURE, 2007, 15 (05) : 545 - 552
  • [6] PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk Great Expectations
    Waters, David D.
    Hsue, Priscilla Y.
    [J]. CIRCULATION RESEARCH, 2015, 116 (10) : 1643 - 1645
  • [7] Evolocumab (Repatha) A Second PCSK9 Inhibitor to Lower LDL-Cholesterol
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1479): : 139 - 140
  • [8] PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
    Luquero, Aureli
    Badimon, Lina
    Borrell-Pages, Maria
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDL-Cholesterol
    Wang, Yan
    Liu, Zhao-Peng
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 19 (02) : 165 - 176
  • [10] The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy
    Feng, Q.
    Wei, W. Q.
    Chung, C. P.
    Levinson, R. T.
    Bastarache, L.
    Denny, J. C.
    Stein, C. M.
    [J]. PHARMACOGENOMICS JOURNAL, 2017, 17 (02): : 204 - 208
12345